

Security policy (edit with Customer reassurance module)
Delivery policy (edit with Customer reassurance module)
Return policy (edit with Customer reassurance module)
1 pill contains the active substance: Bromhexine hydrochloride - 8.0 mg
Pharmacotherapeutic group
Mucolytic agent
The drug has mucolytic (secretolytic) and expectorant effect. The mucolytic effect is associated with the depolymerization and dilution of mucoprotein and mucopolysaccharide fibers. Bromhexine has a weak antitussive effect.
Bronchopulmonary diseases accompanied by the formation of sputum of increased viscosity (bronchial asthma, cystic fibrosis, tuberculosis, pneumonia, tracheobronchitis, obstructive bronchitis, bronchiectasis, pulmonary emphysema, pneumoconiosis), chest trauma, pre- and postoperative period.
- Hypersensitivity to the drug; - pregnancy (I term); - lactation period; - children's age up to 3 years.
Bromhexine is applied internally, regardless of the meal. Adults appoint 1-2 pills 3-4 times a day; children from 3 to 5 years old - 2 mg, from 6 to 14 years old - 4 mg 3 times a day. The course of treatment is from 4 to 28 days. In the course of treatment, it is recommended to consume a sufficient amount of liquid, which supports the secretolytic action of Bromhexine.